mhurhangee/ep-ind-claims huggingface dataset:
An adjustable cosmetic applicator comprising: a handle unit adapted to be used as a cap coupled to a cosmetic container body; a rod unit adapted to be manipulated by means of the handle unit; and an applying unit adapted to be operated cooperatively with the rod unit in such a manner as to be adjusted in angle wherein the applying unit has a brush rod having a brush disposed at one end thereof and a pinion driving part disposed at the other end thereof in such a manner as to be rotated around a rotary shaft through the reception of the linear motion of the rod unit, characterized in that the applying unit has an elastic member adapted to provide an elastic restoring force thereto, the elastic member being supported against the rod unit at one end thereof and against the applying unit at the other end thereof, around the rotary shaft. a handle unit adapted to be used as a cap coupled to a cosmetic container body; a rod unit adapted to be manipulated by means of the handle unit; and an applying unit adapted to be operated cooperatively with the rod unit in such a manner as to be adjusted in angle wherein the applying unit has a brush rod having a brush disposed at one end thereof and a pinion driving part disposed at the other end thereof in such a manner as to be rotated around a rotary shaft through the reception of the linear motion of the rod unit, characterized in that the applying unit has an elastic member adapted to provide an elastic restoring force thereto, the elastic member being supported against the rod unit at one end thereof and against the applying unit at the other end thereof, around the rotary shaft.
A bone harvesting tool for extraction of bone and/or cellular material from a patient during a surgical procedure, the tool comprising: a chamber having a first aperture, a second aperture, an internal cavity, and a suction source fluidly connected with the chamber,; a reamer having a reaming portion, the reamer being sized to extend through the first and second apertures (30, 32) of the chamber, wherein the reamer is movable relative to the chamber; and a storage container threadably coupled to the chamber and fluidly connected to the internal cavity of the chamber and effective to receive bone and/or cellular material extracted from the patient, the bone and/or cellular material being extracted during reaming a bone of the patient with the reamer, characterized in that the chamber further includes an opening sized and configured to accept a connector engaging with the opening to connect a suction tubing fluidly coupling to a suction source being effective to generate negative pressure within the internal cavity of the chamber, and in that the opening is spaced apart from the storage container. a chamber having a first aperture, a second aperture, an internal cavity, and a suction source fluidly connected with the chamber,; a reamer having a reaming portion, the reamer being sized to extend through the first and second apertures (30, 32) of the chamber, wherein the reamer is movable relative to the chamber; and a storage container threadably coupled to the chamber and fluidly connected to the internal cavity of the chamber and effective to receive bone and/or cellular material extracted from the patient, the bone and/or cellular material being extracted during reaming a bone of the patient with the reamer, characterized in that the chamber further includes an opening sized and configured to accept a connector engaging with the opening to connect a suction tubing fluidly coupling to a suction source being effective to generate negative pressure within the internal cavity of the chamber, and in that the opening is spaced apart from the storage container.
A method implemented by a virtual edge network function, VENF, to establish a communication session between a residential gateway and the VENF in a network function virtualization infrastructure, NFVI, over an access network where a plurality of residential gateways are connected to the access network through a plurality of access nodes that tunnel edge network function requests to the NFVI via a NFVI gateway that broadcasts initial service requests to a plurality of VENF in the NFVI, where the VENF self-selects to service an initial service session request from the residential gateway, the method comprising the steps of: receiving the initial service session request from the NFVI gateway via a broadcast domain or emulation of a broadcast domain; determining via criteria received as part of the service session request that the VENF is a candidate to service the session; sending a service session request response to the residential gateway identifying an address of the VENF to service the session; and exchanging data traffic with the residential gateway over the session between the residential gateway and the VENF upon completion of session establishment confirmation. receiving the initial service session request from the NFVI gateway via a broadcast domain or emulation of a broadcast domain; determining via criteria received as part of the service session request that the VENF is a candidate to service the session; sending a service session request response to the residential gateway identifying an address of the VENF to service the session; and exchanging data traffic with the residential gateway over the session between the residential gateway and the VENF upon completion of session establishment confirmation.
Combination of an end connection device for wire ropes with a wire rope to be received therein which has helically arranged outer strands, which end connection device is designed as a one-piece sleeve-shaped body having an inner lateral surface and an outer lateral surface for arrangement around an end portion of the wire rope, the sleeve-shaped body having, on the inner lateral surface, grooves which extend helically in the longitudinal direction of the inner lateral surface in order to form an inner profile of the sleeve-shaped body which corresponds to an outer profile of the wire rope, in which grooves portions of the outer strands can be received, characterised in that the sleeve-shaped body is designed as a hollow cylinder having a substantially constant outer diameter (Da) and in that the ratio of an enveloping circle diameter of the wire rope to be received with respect to an enveloping circle diameter (Dh) of the inner lateral surface of the hollow cylinder is between 1 and 1.15, preferably approximately 1.09.
An exhaust purification system of an internal combustion engine (100, 100a, 100b, 100c) comprising: a catalyst arranged in an exhaust passage of the internal combustion engine (100, 100a, 100b, 100c) and able to store oxygen; an ammonia detection device (46, 71) arranged in the exhaust passage at a downstream side of the catalyst in a direction of flow of exhaust; an air-fuel ratio control part configured to control an air-fuel ratio of inflowing exhaust gas flowing into the catalyst to a target air-fuel ratio, wherein the air-fuel ratio control part is configured to perform rich control making the target air-fuel ratio richer than a stoichiometric air-fuel ratio, and make the target air-fuel ratio leaner than the stoichiometric air-fuel ratio when an output value of the ammonia detection device (46, 71) rises to a reference value in the rich control; and characterized by a temperature detection part configured to detect or estimate a temperature of the catalyst or a temperature of exhaust gas flowing out from the catalyst, wherein the air-fuel ratio control part is configured to make the reference value smaller the higher the temperature detected or estimated by the temperature detection part. a catalyst arranged in an exhaust passage of the internal combustion engine (100, 100a, 100b, 100c) and able to store oxygen; an ammonia detection device (46, 71) arranged in the exhaust passage at a downstream side of the catalyst in a direction of flow of exhaust; an air-fuel ratio control part configured to control an air-fuel ratio of inflowing exhaust gas flowing into the catalyst to a target air-fuel ratio, wherein the air-fuel ratio control part is configured to perform rich control making the target air-fuel ratio richer than a stoichiometric air-fuel ratio, and make the target air-fuel ratio leaner than the stoichiometric air-fuel ratio when an output value of the ammonia detection device (46, 71) rises to a reference value in the rich control; and characterized by a temperature detection part configured to detect or estimate a temperature of the catalyst or a temperature of exhaust gas flowing out from the catalyst, wherein the air-fuel ratio control part is configured to make the reference value smaller the higher the temperature detected or estimated by the temperature detection part.
An extruded polymer foam comprising: a. a polymer matrix wherein greater than 50 weight-percent of all polymers in the polymer matrix are alkenyl aromatic polymers; b. 0.8 weight-percent or more and 1.4 weight-percent or less of bromide within the polymer matrix based on polymer matrix weight; c. 0.05 weight-percent or more and 0.5 weight-percent or less of a hydrobromic acid scavenger dispersed within the polymer matrix based on polymer matrix weight; and d. less than 0.1 weight-percent of C-C and O-O labile organic compounds dispersed in the polymer matrix based on polymer matrix weight e. from 0.5 to 10 weight percent graphite based on polymer matrix weight, wherein a hydrobromic acid scavenger is a material that reacts with hydrobromic acid to form covalent carbon-bromine bonds, wherein the extruded polymer foam achieves a B2 rating in the German B2 fire test according to DIN 4102. a. a polymer matrix wherein greater than 50 weight-percent of all polymers in the polymer matrix are alkenyl aromatic polymers; b. 0.8 weight-percent or more and 1.4 weight-percent or less of bromide within the polymer matrix based on polymer matrix weight; c. 0.05 weight-percent or more and 0.5 weight-percent or less of a hydrobromic acid scavenger dispersed within the polymer matrix based on polymer matrix weight; and d. less than 0.1 weight-percent of C-C and O-O labile organic compounds dispersed in the polymer matrix based on polymer matrix weight e. from 0.5 to 10 weight percent graphite based on polymer matrix weight,
A wire plug-in aid sleeve structure for wire connection terminal, comprising at least one aid sleeve assembly (10,10a~10f,20, 20a~20g) composed of at least one aid sleeve(1,1a~1f,2, 2a-2g), the aid sleeve(1,1a~1f,2, 2a~2g) being formed with an internal guide hole (15, 25) passing through the aid sleeve(1,1a~1f,2, 2a-2g), the aid sleeve(1,1a∼1f,2, 2a~2g) having a wire collection section (14, 14a, 14b, 24, 24a, 24b) protruding from one side of one end of the guide hole (15, 25), a recessed guide channel (141, 241) being disposed on one side of the wire collection section (14, 14a, 14b, 24, 24a, 24b) proximal to the guide hole (15, 25), the recessed guide channel (141, 241) communicating with the guide hole(15, 25), wherein the recessed guide channel (141, 241) includes two lateral outer arched channels with larger curvature radius, the two lateral outer arched channels gradually extending toward a middle bottom face to form an inner arched channel with smaller curvature radius.
A non-addictive anesthetic analgesic sustained-release drug delivery system consisting of an anesthetic analgesic, a drug menstruum, and a drug sustained-release agent; characterized in that the sustained-release drug delivery system is an oily solution having good homogeneity; and the anesthetic analgesic comprises a local anesthetic, a nonsteroidal anti-inflammatory analgesic and an opioid analgesic at non-addictive medium or low dose; wherein the local anesthetic comprises a free base of procaine, lidocaine, bupivacaine, levobupivacaine, ropivacaine, tetracaine, dibucaine or etidocaine or salts thereof; the nonsteroidal anti-inflammatory analgesic comprises aspirin, diclofenac sodium, ibuprofen, naproxen, nabumetone, sulindac, mefenamic acid, clofenamic acid, diclofenac, flufenamic acid, piroxicam, meloxicam, aminopyrine, analgin, phenacetin, paracetamol, parecoxib, rofecoxib, valdecoxib, or nimesulide; and the opioid analgesic comprises dihydromorphinone, dezocine, naloxone, naltrexone, morphine, fentanyl, sufentanil, codeine, pethidine, pentazocine, methadone, etorphine, bucinnazine, buprenorphine, tramadol, alfentanil, or remifentanil; the drug menstruum comprises one or a mixture of two or more of benzyl alcohol, ethanol, glycerol monoacetate, ethyl lactate, tetrahydrofurfuryl polyethylene glycol ether, and benzyl benzoate; and the drug sustained-release agent comprises a natural vegetable oil, an artificially modified semi-natural fat from natural vegetable oil, purified fat, artificially synthesized fat, animal fat having a low melting point, or a mixture of two or more of natural vegetable oil, artificially modified semi-natural fat from natural vegetable oil, purified fat, artificially synthesized fat and animal fat having a low melting point.
A printing machine provided with a main gear and plate cylinder driving devices driving individual plate cylinders, wherein each of said plate cylinder driving devices is provided with a drive shaft driving a plate cylinder, a drive helical gear fixed to the drive shaft, and an anti-backlash helical gear which is rotatably connected to the drive shaft and is biased by at least a spring towards a direction for preventing backlash; and wherein the drive helical gear and the anti-backlash helical gear are both engaged with the main gear; characterized in that a plate provided with plural holes in which rollers are accommodated is provided between the drive helical gear and the anti-backlash helical gear.
A method for a base station to reallocate a resource comprising: generating a rearrangement information element, IE, including slot offset information and slot shift information of a fixed radio resource to be rearranged; transmitting the rearrangement IE to a mobile station; and shifting a slot of the fixed radio resource by the slot shift information to reallocate a resource to the mobile station. generating a rearrangement information element, IE, including slot offset information and slot shift information of a fixed radio resource to be rearranged; transmitting the rearrangement IE to a mobile station; and shifting a slot of the fixed radio resource by the slot shift information to reallocate a resource to the mobile station.
A composition for use in treating a patient having a cancer, wherein cells of the cancer have been tested for: (i) a hemizygous loss of the TP53 gene; (ii) a hemizygous loss of the POLR2A gene; or (iii) a decreased level of expression of a POLR2A gene product relative to a reference expression level, the composition comprising a therapeutically effective amount of a POLR2A inhibitor, wherein the POLR2A inhibitor comprises an amatoxin, and wherein the amatoxin is conjugated to an antibody which specifically binds to a tumor- associated antigen.
An endoluminal prosthesis deployment system, comprising: a prosthesis including a support structure coupled to a graft body, the prosthesis having a first end opening, a second end opening, a lumen extending longitudinally between the first and second end openings, an anterior fenestration disposed in a sidewall of the graft body of the prosthesis below the first end opening, at least one lateral fenestration disposed in the sidewall below the anterior fenestration and circumferentially spaced from the anterior fenestration, the at least one lateral fenestration configured to receive a secondary graft, and an opening disposed in the sidewall below the at least one lateral fenestration; and a guide disposed such that it extends from below the second end opening, extends through the lumen to the at least one lateral fenestration, exits the at least one lateral fenestration, traverses along an exterior surface of the prosthesis, enters the anterior fenestration, longitudinally traverses along an interior surface of the prosthesis, and exits the opening to extend away from the opening toward the second end opening of the prosthesis. a prosthesis including a support structure coupled to a graft body, the prosthesis having a first end opening, a second end opening, a lumen extending longitudinally between the first and second end openings, an anterior fenestration disposed in a sidewall of the graft body of the prosthesis below the first end opening, at least one lateral fenestration disposed in the sidewall below the anterior fenestration and circumferentially spaced from the anterior fenestration, the at least one lateral fenestration configured to receive a secondary graft, and an opening disposed in the sidewall below the at least one lateral fenestration; and a guide disposed such that it extends from below the second end opening, extends through the lumen to the at least one lateral fenestration, exits the at least one lateral fenestration, traverses along an exterior surface of the prosthesis, enters the anterior fenestration, longitudinally traverses along an interior surface of the prosthesis, and exits the opening to extend away from the opening toward the second end opening of the prosthesis.
Recombinant cells capable of producing isoprene, wherein the cells comprise: (i) (a) a nucleic acid encoding a YfiQ polypeptide, wherein the cells have been modified such that the activity of the YfiQ polypeptide is modulated by decreasing, attenuating, or deleting the expression of the nucleic acid encoding the YfiQ polypeptide, and/or (b) a nucleic acid encoding a CobB polypeptide, wherein the cells have been modified such that the activity of the CobB polypeptide is modulated by increasing the expression of the nucleic acid encoding the CobB polypeptide; (ii) one or more nucleic acids encoding one or more polypeptides of the MVA pathway; (iii) a heterologous nucleic acid encoding a polypeptide having isoprene synthase activity; and (iv) one or more heterologous nucleic acids encoding a polypeptide having phosphoketolase activity, wherein culturing of the recombinant cells in a suitable media provides for the production of isoprene. (i) (a) a nucleic acid encoding a YfiQ polypeptide, wherein the cells have been modified such that the activity of the YfiQ polypeptide is modulated by decreasing, attenuating, or deleting the expression of the nucleic acid encoding the YfiQ polypeptide, and/or (b) a nucleic acid encoding a CobB polypeptide, wherein the cells have been modified such that the activity of the CobB polypeptide is modulated by increasing the expression of the nucleic acid encoding the CobB polypeptide; (a) a nucleic acid encoding a YfiQ polypeptide, wherein the cells have been modified such that the activity of the YfiQ polypeptide is modulated by decreasing, attenuating, or deleting the expression of the nucleic acid encoding the YfiQ polypeptide, and/or (b) a nucleic acid encoding a CobB polypeptide, wherein the cells have been modified such that the activity of the CobB polypeptide is modulated by increasing the expression of the nucleic acid encoding the CobB polypeptide; (ii) one or more nucleic acids encoding one or more polypeptides of the MVA pathway; (iii) a heterologous nucleic acid encoding a polypeptide having isoprene synthase activity; and (iv) one or more heterologous nucleic acids encoding a polypeptide having phosphoketolase activity,
A communication method, comprising: selecting, by a distributed unit, DU, any one of F1 interface user plane, F1-U, tunnels on which packet loss occurs, wherein the F1-U tunnels are established between a user plane entity of a centralized unit, CU-UP, and the DU and that are of a user equipment, UE, sending, by the DU to the CU-UP on the selected F1-U tunnel, a message for feeding back a downlink transmission status, wherein the message comprises packet loss information and an indication, the indication is used to indicate radio link outage or radio link resume between the DU and the UE, and sending, by the DU to the CU-UP, a second message for feeding back a downlink transmission status on another F1-U tunnel on which packet loss occurs, wherein the second message only comprises packet loss information and does not comprise the indication. selecting, by a distributed unit, DU, any one of F1 interface user plane, F1-U, tunnels on which packet loss occurs, wherein the F1-U tunnels are established between a user plane entity of a centralized unit, CU-UP, and the DU and that are of a user equipment, UE, sending, by the DU to the CU-UP on the selected F1-U tunnel, a message for feeding back a downlink transmission status, wherein the message comprises packet loss information and an indication, the indication is used to indicate radio link outage or radio link resume between the DU and the UE, and sending, by the DU to the CU-UP, a second message for feeding back a downlink transmission status on another F1-U tunnel on which packet loss occurs, wherein the second message only comprises packet loss information and does not comprise the indication.
A method for generating focused ultrasonic waves over a focal zone to produce biological lesions, comprising the activation of a plurality of ultrasonic transducer elements distributed over an emission surface to respectively emit a plurality of focused ultrasonic waves in the focal zone, while crossing through propagation media ( E i) having different acoustic attenuations, characterized in that: - a target zone is chosen in which homogenization of the energy contributions of the ultrasonic waves emitted by the ultrasonic transducer elements is desired, - the focal effect and the acoustic attenuations of the ultrasonic waves on their paths between the target zone and the ultrasonic transducer elements are determined, - the focal effect and the acoustic attenuations of the ultrasonic waves are compensated, with ultrasonic transducer elements, at least some of which have non-identical emission surfaces so that in the target zone, the energy contribution of the ultrasonic waves emitted by the various ultrasonic transducer elements are substantially identical, - the ultrasonic transducer elements are activated by excitation signals of substantially identical values so that in the target zone, the energy contribution of the ultrasonic waves emitted by the various ultrasonic transducers are substantially identical and produce biological lesions. - a target zone is chosen in which homogenization of the energy contributions of the ultrasonic waves emitted by the ultrasonic transducer elements is desired, - the focal effect and the acoustic attenuations of the ultrasonic waves on their paths between the target zone and the ultrasonic transducer elements are determined, - the focal effect and the acoustic attenuations of the ultrasonic waves are compensated, with ultrasonic transducer elements, at least some of which have non-identical emission surfaces so that in the target zone, the energy contribution of the ultrasonic waves emitted by the various ultrasonic transducer elements are substantially identical, - the ultrasonic transducer elements are activated by excitation signals of substantially identical values so that in the target zone, the energy contribution of the ultrasonic waves emitted by the various ultrasonic transducers are substantially identical and produce biological lesions.
Composition, notably a cosmetic composition, characterized in that it comprises, notably in a cosmetically acceptable medium: (a) at least one photoprotective system capable of screening out UV radiation; (b) at least one carboxylic acid ester comprising at least 12 carbon atoms, said ester comprising at least 24 carbon atoms; (c) at least one C 8 -C 30 alkyl(poly)glycoside, the carboxylic acid ester(s) being chosen from behenyl behenate and arachidyl arachidate, and more particularly behenyl behenate. (a) at least one photoprotective system capable of screening out UV radiation; (b) at least one carboxylic acid ester comprising at least 12 carbon atoms, said ester comprising at least 24 carbon atoms; (c) at least one C 8 -C 30 alkyl(poly)glycoside,